Skip to content
HowShorted

Gossamer Bio, Inc. short interest in 2025

In 2025, Gossamer Bio, Inc.'s disclosed short interest ran from 2.76% of shares outstanding on 15 Jan 2025 to 10.42% on 31 Dec 2025, a change of +7.66 percentage points. The year's high was 12.05% on 30 Sep 2025 and its low 2.47% on 28 Feb 2025, averaging 6.94% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.65 days on 15 Jul 2025. Full history: Gossamer Bio, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Gossamer Bio, Inc. in 2025

2025 in figures

Start of year
2.76% (15 Jan 2025)
End of year
10.42% (31 Dec 2025)
Change
+7.66 pp
High
12.05% (30 Sep 2025)
Low
2.47% (28 Feb 2025)
Average
6.94%
Highest days to cover
11.65 (15 Jul 2025)
SEC filings marked
8

Every report in 2025

Gossamer Bio, Inc. short interest in 2025
SettlementShort interestDays to coverFilings since previous
15 Jan 20252.76%4.79
31 Jan 20252.56%8.86
14 Feb 20252.52%2.91
28 Feb 20252.47%2.90
14 Mar 20252.53%3.9010-K filed, results (8-K)
31 Mar 20253.51%5.43
15 Apr 20254.04%5.68
30 Apr 20254.43%5.90
15 May 20254.64%7.2410-Q filed, results (8-K)
30 May 20254.88%6.64
13 Jun 20254.87%8.66
30 Jun 20257.44%4.31
15 Jul 20257.97%11.65
31 Jul 20258.24%5.16
15 Aug 20259.02%6.8110-Q filed, results (8-K)
29 Aug 20259.70%7.14
15 Sep 202510.55%4.23
30 Sep 202512.05%6.44
15 Oct 202511.77%8.24
31 Oct 202510.77%8.01
14 Nov 202510.55%9.4510-Q filed, results (8-K)
28 Nov 202510.13%8.22
15 Dec 20258.78%5.73
31 Dec 202510.42%4.66

See also: Gossamer Bio, Inc.'s full history · most shorted US stocks of 2025 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.